Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Total Debt: 2021-2025

Historic Total Debt for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Sep 2025 value amounting to $5,611.

  • ProQR Therapeutics N.V's Total Debt rose 213.29% to $5,611 in Q3 2025 from the same period last year, while for Sep 2025 it was $5,611, marking a year-over-year increase of 213.29%. This contributed to the annual value of $9.8 million for FY2024, which is 210823.39% up from last year.
  • As of Q3 2025, ProQR Therapeutics N.V's Total Debt stood at $5,611, which was down 99.90% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Total Debt ranged from a high of $50.4 million in Q4 2021 and a low of -$4.8 million during Q2 2024.
  • Over the past 3 years, ProQR Therapeutics N.V's median Total Debt value was $3.1 million (recorded in 2023), while the average stood at $2.4 million.
  • Its Total Debt has fluctuated over the past 5 years, first slumped by 222.74% in 2024, then skyrocketed by 213.29% in 2025.
  • ProQR Therapeutics N.V's Total Debt (Quarterly) stood at $50.4 million in 2021, then tumbled by 86.30% to $6.9 million in 2022, then slumped by 33.15% to $4.6 million in 2023, then surged by 112.06% to $9.8 million in 2024, then spiked by 213.29% to $5,611 in 2025.
  • Its Total Debt was $5,611 in Q3 2025, compared to $5.4 million in Q2 2025 and $4,897 in Q1 2025.